SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-12-003871
Filing Date
2012-01-17
Accepted
2012-01-17 16:36:29
Documents
1
Period of Report
2012-01-07

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c26732_3x0.html 3  
1 MAIN DOCUMENT DESCRIPTION c26732_3x0.xml 3 6614
  Complete submission text file 0001209191-12-003871.txt   8958
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Reporting) CIK: 0000014272 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-50772 | Film No.: 12529973
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004
Business Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004 678-746-1100
INHIBITEX, INC. (Issuer) CIK: 0001274913 (see all company filings)

IRS No.: 742708737 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 (212) 546-4000
Inta Acquisition Corp (Reporting) CIK: 0001539753 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 000-50772 | Film No.: 12529974